CBDNewsBreaks – Earth Science Tech Inc. (ETST) Targets Emergent Biotechnology Cannabis Sector

October 14, 2019 14:21:56

Earth Science Tech (OTCQB: ETST) holds a robust portfolio of products targeting the largest segment of the rising legal cannabis market: biotechnology. An article discussing the company reads, “Earth Science Tech is well-positioned as a biotechnology company which focuses on the research and development of CBD, pharmaceuticals and medical device products. The company’s pure CBD oil is manufactured using CO2 liquid extraction processes; ETST prides itself on offering the finest quality pure CBD oil on the market. . . . The biotechnology segment of the cannabis industry consists of pharmaceutical firms focused on the research and development behind new drugs and products that utilize cannabinoids, which are the active compounds within cannabis. Currently the largest sector in the legal cannabis market, it is expected to see further growth as more entities around the world continue researching cannabinoids (http://cnw.fm/b5sGr). This trend is encouraging for biotechnology companies like Florida-based ETST.”

To view the full article, visit http://cnw.fm/QaZ2n

About Earth Science Tech Inc.

Earth Science Tech offers the highest purity and quality high-grade, full-spectrum cannabinoid oil on the market. ETST notes positive results in studies on breast cancer and immune cells conducted through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the company’s CBD-oil formulation lowers cortisol and functions as a neuroprotectant, with positive-result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most-effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]